From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...

In February, Takeda signed an MoU on rare diseases with the Medical Services Administration under the Ministry of Health, in ...

Effective dengue prevention requires a combination of vector control and vaccination efforts, a group of physicians said ...

People infected a second time are at especially high risk. There is no specific medication to treat dengue. Japanese ...

Climate change and mosquitos are creating an epidemic of dengue in Oaxaca, as researchers work to counteract the disease.

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

School-entry immunization requirements are a valuable strategy to reduce the spread of vaccine-preventable diseases. This research examined the temporal relationship between recommendations issued by ...

With dengue fever spreading to colder climates, Island Pharmaceuticals is working on a preventative and therapeutic solution.

Dr. Nina Gloriani, Head of the Department of Science and Technology’s (DOST) Vaccine Expert Panel, highlighted the cyclical nature of dengue and the increasing morbidity rates. “We’ve seen ...

Sanofi is on course to launch the first vaccine against dengue fever, a mosquito-borne viral infection that threatens millions of the world's population, later this year.

All growth rates mentioned below are on a year-on-year basis and at CER. Sanofi’s Biopharma segment includes Pharma and Vaccines. Biopharma sales rose 16.6% in the quarter to €12.17 billion. Pharma ...